Review of the use of biofeedback in the treatment of patients with depressive disorders
S.A. Galkin1, G.G. Simutkin1, E.D. Schastnyy1, S.A. Ivanova1, 2, N.A. Bokhan1, 2
1 Mental Health Research Institute, Tomsk National Research Medical Center (NRMC) of the Russian Academy of Sciences, Tomsk, Russian Federation
2 Siberian State Medical University (SSMU), Tomsk, Russian Federation
SUMMARY:
The article presents a literary review of research on the use of biofeedback methods in the treatment of depressive disorders. The problem of effective therapy, prevention and rehabilitation of patients with depressive disorders is of particular relevance in modern conditions. Despite the appearance of a large number of modern antidepressants, the number of therapeutically resistant patients is about 30 %. In this regard, the interest of specialists in the use of non-drug therapy methods in the treatment of depression is currently growing.
The purpose of the study is to systematize scientific data on the effectiveness of the use of biofeedback methods in the treatment of patients with depressive disorders.
Conclusions: bio-management methods have proven to be quite effective in reducing symptoms of depression and improving the well-being of patients. However, despite the fact that there is no evidence that bio-management methods are ineffective, additional research is needed to clearly recommend their use in clinical practice.
Research material and methods: the keywords “neurofeedback”, “depression”, “biofeedback”, “electroencephalography”, “electromyogram”, “respiratory training”, “relaxation” were selected in databases (MEDLINE/PubMed and other sources) scientific publications from 1980 to 2019.
CONTACT: s01091994@yandex.ru
1. Krasnov V.N. Depressija kak social'naja i klinicheskaja problema sovremennoj mediciny // Rossijskij psihiatricheskij zhurnal. - 2011. - N 6. - P. 8-10.
2. Kessler R.C., Bromet E.J. The epidemiology of depression across cultures // Annu. Rev. Public Health. - 2013. - Vol. 34. - P. 119‐138. - DOI: 10.1146/annurev-publhealth-031912-114409
3. Kulikov A.Ju., Dedjurina Ju.M. Analiz stoimosti bolezni lechenija pacientov, stradajushhih depressivnymi rasstrojstvami, v uslovijah zdravoohranenija Rossijskoj Federacii // Farmakojekonomika. Sovremennaja farmakojekonomika i farmakojepidemiologija. - 2011. - N 1. - P. 24-33.
4. Freeman A., Tyrovolas S., Koyanagi A. The role of socio-economic status in depression: results from the COURAGE (aging survey in Europe) // BMC Public Health. - 2016. - Vol. 16, No. 1. - P. 1098. - DOI: 10.1186/s12889-016-3638-0
5. Vasil'ev V.V., Kovalev Ju.V., Imasheva Je.R. Suicidal'nye mysli pri depressivnom sindrome // Suicidologija. - 2014. - N 1. - P. 30-35.
6. Bachmann S. Epidemiology of Suicide and the Psychiatric Perspective // Int. J. Environ Res. Public Health. - 2018. - Vol. 15, No. 7. - P. 1425. - DOI:10.3390/ijerph15071425
7. Simutkin G.G. Osobye patterny techenija affektivnyh rasstrojstv. - Tomsk: Izd-vo Tom. un-ta, 2010. - S. 9-15.
8. Smulevich A.B., Andrjushenko A.V., Romanov D.V., Zaharova N.V. Remissii pri affektivnyh zabolevanijah: jepidemiologija, psihopatologija, klinicheskij i social'nyj prognoz, vtorichnaja profilaktika // Zhurnal nevrologii i psihiatrii.-2014.- N 3.- P. 4-13.
9. Vasil'eva S.N., Simutkin G.G., Schastnyj E.D., Smirnova N.S., Gorshkova L.V., Luk'janova E.V., Balycheva T.A. Jeffektivnost' psihofarmakoterapii v sochetanii s interpersonal'noj i social'noj ritmicheskoj psihoterapiej // Sibirskij vestnik psihiatrii i narkologii. - 2018. - N 1. - P. 104-107.
10. Mosolov S.N., Kostukova E.G. Lechenie bolnih s recurrentnim depressivnim rasstroistvom // V knige: Psihiatriya: natsionalnoe rukovodstvo / red. Neznanov N.G., Aleksandrovskiy U.A./ Moskva, 2018. С. 347-378.
11. Gorodnichev A.V., Kostjukova E.G. Sravnitel'naja profilakticheskaja jeffektivnost' paroksetina, fluoksetina, tianeptina i amitriptilina pri dlitel'noj terapii rekurrentnogo depressivnogo rasstrojstva s chastymi recidivami / V kn.: Biologicheskie metody terapii psihicheskih rasstrojstv. Red. Mosolov S.N. Dokazatel'naja medicina - klinicheskoj praktike. Moskva, 2012. S. 365-386.
12. Mosolov S.N., Egorov A.Ju., Skoromec T.A., Cukarzi Je.Je., Gorelik A.L., Naryshkin A.G., Anichkov A.D., Poljakov Ju.I. Nelekarstvennye metody biologicheskoj terapii v psihiatrii // V knige: Psihiatrija: nacional'noe rukovodstvo / red. Neznanov N.G., Aleksandrovskij Ju.A. / Moskva, 2018. S. 952-995
13. Puzin M.N., Kiparisova E.S., Hozhenko E.V., Lepaev Ju.V., Denishhuk I.S., Afanas'ev B.G., Dymochka M.A., Shtelle A.A., Prokof'ev A.S., Tarasova L.A. Bioupravlenie i bolevye rasstrojstva // Mediko-social'naja jekspertiza i reabilitacija. - 2017. - N 3. - P. 162-168.
14. Linden D.E. Neurofeedback and networks of depression // Dialogues Clin. Neurosci. 2014. - Vol. 16, No. 1. - P. 103‐112.
15. Allen J.J., Reznik S.J. Frontal EEG Asymmetry as a Promising Marker of Depression Vulnerability: Summary and Methodological Considerations // Curr. Opin. Psychol. 2015. - Vol. 101, No. 4. - P. 93‐97. - DOI: 10.1016/j.copsyc.2014.12.017
16. Shi Y., Yang D., Zeng Y., Wu W. Risk Factors for Post-stroke Depression: A Meta-analysis // Front. Aging. Neurosci. - 2017. - Vol. 9. - P. 218. - DOI: 10.3389/fnagi.2017.00218
17. Sutton S.K., Davidson R.J., Science S.P., May N. Prefrontal brain asymmetry: A biological substrate of the behavioral approach and inhibition systems // Psychol. Sci. 2014. - Vol. 8. - P. 204-210.
18. Thibodeau R., Jorgensen R.S., Kim S. Depression, anxiety, and resting frontal EEG asymmetry: a meta-analytic review // J Abnorm. Psychol. - 2006. - Vol. 115. - P. 715-729.
19. Quaedflieg C.W., Smulders F.T., Meyer T., Peeters F., Merckelbach H., Smeets T. The validity of individual frontal alpha asymmetry EEG neurofeedback // Soc. Cogn. Affect. Neurosci. - 2016. - Vol.11, No. 1. - P. 33‐43. - DOI:10.1093/scan/nsv090
20. Baehr E., Rosenfeld J.P., Baehr R. The Clinical Use of An Alpha Asymmetry Protocol in the Neurofeedback Treatment of Depression: Two Case Studies // Journal of Neurotherapy. - 1997. - Vol. 2, No. 3. - P. 10-23. - DOI: 10.1300/J184v02n03_02
21. Lee Y.J., Lee G.W., Seo W.S., Koo B.H., Kim H.G., Cheon E.J. Neurofeedback Treatment on Depressive Symptoms and Functional Recovery in Treatment-Resistant Patients with Major Depressive Disorder: an Open-Label Pilot Study // J. Korean. Med. Sci. - 2019. - Vol. 34, No. 42. - P. e287. - DOI: 10.3346/jkms.2019.34.e287
22. Baehr E., Rosenfeld J.P., Baehr R. Clinical Use of an Alpha Asymmetry Neurofeedback Protocol in the Treatment of Mood Disorders // Journal of Neurotherapy. - 2016. - Vol. 4, No. 4. - DOI: 10.1300/J184v04n04_03
23. Wang Yu., Lin I., Peper E., Chen Yu., Tang T., Yeh Yi., Tsai Yu., Chu C. The efficacy of neurofeedback among patients with major depressive disorder: preliminary study // NeuroRegulation. - 2016. - Vol. 3, No. 3. - DOI: 10.15540/nr.3.3.127
24. Cheon E., Koo B., Choi J. The Efficacy of Neurofeedback in Patients With Major Depressive Disorder: An Open Labeled Prospective Study // Appl. Psychophysiol. Biofeedback. - 2016. - Vol. 41, No. 1. - P. 103-10. - DOI: 10.1007/s10484-015-9315-8
25. Walker E., Lawson R. FP02 Beta Training for Drug-Resistant Depression - A New Protocol That Usually Reduces Depression and Keeps It Reduced // Journal of Neurotherapy: Investigations in Neuromodulation, Neurofeedback and Applied Neuroscience. - 2013. - Vol. 17, No. 3. - P. 198- 200. - DOI: 10.1080/10874208.2013.785784
26. Marzbani H., Marateb H.R., Mansourian M. Neurofeedback: A Comprehensive Review on System Design, Methodology and Clinical Applications // Basic. Clin. Neurosci. - 2016. - Vol. 7, No. 2. - P. 143‐158. - DOI: 10.15412/J.BCN.03070208
27. Hurt E., Arnold L. E., Lofthouse N. Quantitative EEG Neurofeedback for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorders, Learning Disorders, and Epilepsy // Child and Adolescent Psychiatric Clinics of North America. - 2014. - Vol. 23, No. 3. - P. 465-486.
28. Galkin S.A., Peshkovskaja A.G., Simutkin G.G., Vasil'eva S.N., Roshhina O.V., Ivanova S.A., Bohan N.A. Narushenija funkcii prostranstvennoj rabochej pamjati pri depressii legkoj stepeni tjazhesti i ih nejrofiziologicheskie korreljaty // Zhurnal nevrologii i psihiatrii im. C.C. Korsakova. - 2019. - N 10. - P. 56-61.
29. Perini G, Cotta Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A. Cognitive impairment in depression: recent advances and novel treatments // Neuropsychiatr. Dis. Treat. - 2019. - Vol. 15. P. 1249-1258. - DOI:10.2147/NDT.S199746
30. Escolano C., Navarro-Gil M., Garcia-Campayo J., Congedo M., De Ridder D., Minguez J. A controlled study on the cognitive effect of alpha neurofeedback training in patients with major depressive disorder // Front. Behav. Neurosci. - 2014. - Vol. 8. - P. 296. - DOI:10.3389/fnbeh.2014.00296
31. Galkin S.A., Tkacheva G.D., Simutkin G.G., Vasil'eva S.N., Roshhina O.V., Ivanova S.A., Bohan N.A. Izmenenija pokazatelej biojelektricheskoj aktivnosti mozga pri depressivnyh rasstrojstvah v processe terapii SIOZS // Psihicheskoe zdorov'e. - 2020. - N 3. - P. 3-8.
32. Miograficheskij trening. [Jelektronnyj resurs]. - Rezhim dostupa: https://boslab.ru/methods/boslabMethods/mio_boslab.php (data obrashhenija: 12.05.2020).
33. Gehricke J.G., Shapiro D. Facial and Autonomic Activity in Depression: Social Context Differences During Imagery // Int. J. Psychophysiol. - 2001. - Vol. 41, No. 1. - P. 53-64. - DOI: 10.1016/s0167-8760(00)00181-1
34. Luijcks R., Hermens H.J., Bodar L., Vossen C.J., Van Os J., Lousberg R. Experimentally induced stress validated by EMG activity // PLoS One. - 2014. - Vol. 9, No. 4. - P. e95215. - DOI: 10.1371/journal.pone.0095215
35. Antipova O.S. Rasstrojstva affektivnogo spektra pri hronicheskoj migreni: voprosy komorbidnosti // Vestnik psihiatrii i psihologii Chuvashii. - 2011. - N 7. - P. 8-20.
36. Prishhepa A.V., Danilov A.B. Jeffektivnost' metoda biologicheskoj obratnoj svjazi v lechenii hronicheskoj golovnoj boli naprjazhenija i hronicheskoj migreni // Medicinskij alfavit. - 2018. - N 17. - P. 19-25.
37. Sorokina N.D., Selickij G.V., Il'ina E.S. Primenenie razlichnyh vidov biologicheskoj obratnoj svjazi v terapii golovnoj boli naprjazhenija i ih jeffektivnost' // Sovremennaja nauka: tendencii razvitija. - 2016. - N 12. - P. 179-185.
38.Straub R., Hole G., Wolfersdorf M. Electrodermal hypoactivity in depression: psychobiological marker or differential psychophysiologic disposition? // Schweiz Arch Neurol Und Psychiatrie. - 1992. - Vol. 143, No. 1. - P. 41-59.
39. Sarchiapone M., Gramaglia C., Iosue M. The association between electrodermal activity (EDA), depression and suicidal behaviour: A systematic review and narrative synthesis // BMC Psychiatry. - 2018. - Vol. 18, No. 22. - DOI: 10.1186/s12888-017-1551-4
40. Hadders-Algra M. Early human brain development: Starring the subplate // Neuroscience and Biobehavioral. - 2018. - Vol. 92. - P. 276-290. - DOI:10.1016/j.neubiorev.2018.06.017
41. Johnson S.B., Blum R.W., Giedd J.N. Adolescent maturity and the brain: the promise and pitfalls of neuroscience research in adolescent health policy // J. Adolesc. Health. - 2009. - Vol. 45, No. 3. - P. 216-221. - DOI:10.1016/j.jadohealth.2009.05.016
42. Oberman L., Pascual-Leone A. Changes in plasticity across the lifespan: cause of disease and target for intervention // Prog. Brain. Res. - 2013. - Vol. 207. - P. 91-120. - DOI:10.1016/B978-0-444-63327-9.00016-3